CompletedNCT03034408
Nalmefene and Baclofen Effects on Impulsivity in Alcohol Use
About this title
Nalmefene, Baclofen and Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control Subjects
Read the official source — NCT03034408Medication studyAges 18+SwitzerlandAddiction
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- GenevaSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateJuly 1, 2016
- Recruitment status
- Completed
- Enrollment listed in the registry
- 37
- Sponsor
- Prof. Daniele Zullino
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Switzerland
- Age range
- Over 18 Years
- Official registry ID
- NCT03034408
- Official title
Show the full official title
Effects of Nalmefene and Baclofen on Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control Subjects: A Randomized, Placebo-controlled Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Geneva
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Prof. Daniele Zullino.
Did this study involve medication?
Yes. The study involved medication, including Nalmefene, Baclofen and Placebo Oral Capsule.
Who was this study for?
Listed age limits: from 18 years.
